关键词: 高危良性前列腺增生, 经尿道等离子前列腺电切术;经尿道等离子前列腺剜除术

Abstract:

【Abstract】 Objective To compare the clinical safety and efficacy between transurethral plasm-akinetic enucleation of prostate.(TUPKEP).and transurethral plasmakinetic resection of the prostate(TUPKRP)for treatment of high-risk patients with benign prostatic hyperplasia. Methods The clinical data of 128 cases with high-risk BPH treated with TUPKEP and TUPKRP were analyzed retrospectively. The operation time,.bleeding,.resected tissue weight of prostate,.bladder irrigating time, postoperative hospitalization time, complications, international prostate symptom score (IPSS), quality of life score (QOL), postvoid residua (PVR) and maximum flow rate (Qmax) were compared between two groups..Results Sixty-eight cases and 60 cases underwent TUPKEP procedure and TUPKRP procedure respectively..There was no significant differences observed basic factors in preoperative patients between the two groups (P>0.05). IPSS, QOL, PVR and Qmax were improved in the two groups after the operation.(P<0.01),.and there showed no significant difference between the two groups.(P>0.05)..The operation time,.bleeding,.bladder irrigating time,.and postoperative hospitalization time were significant shorter in TUPKEP than in TUPKRP.(P<0.05)..The resected tissue weight of prostate in TUPKEP was more than in TUPKRP (P<0.05). Conclusion There is no difference in clinical efficiency between two groups,.but TUPKEP has advantages in operation time,.bleeding, postoperative hospitalization time,.mean bladder irrigating time and complications and is an effective and safe therapy for high-risk BPH.

Key words: High-risk benign prostatic hyperplasia, Transurethral plasmakinetic resection of prostate, Transurethral plasmakinetic enucleation of prostate